Details

Autor(en) / Beteiligte

• Chernetsky Tejedor, Sheri
• Tong, David
• Stein, Jason
• Payne, Christina
• Dressler, Daniel
• Xue, Wenqiong
• Steinberg, James P.

Titel

Temporary Central Venous Catheter Utilization Patterns in a Large Tertiary Care Center: Tracking the “Idle Central Venous Catheter”

Ist Teil von

• Infection control and hospital epidemiology, 2012-01, Vol.33 (1), p.50-57

Ort / Verlag

Chicago, IL: University of Chicago Press

Erscheinungsjahr

2012

Quelle

MEDLINE

Beschreibungen/Notizen

• Objectives. Although central venous catheter (CVC) dwell time is a major risk factor for catheter-related bloodstream infections (CR-BSIs), few studies reveal how often CVCs are retained when not needed (“idle”). We describe use patterns for temporary CVCs, including peripherally inserted central catheters (PICCs), on non-ICU wards. Design. A retrospective observational study. Setting. A 579-bed acute care, academic tertiary care facility. Methods. A retrospective observational study of a random sample of patients on hospital wards who have a temporary, nonimplanted CVC, with a focus on on daily ward CVC justification. A uniform definition of idle CVC-days was used. Results. We analyzed 89 patients with 146 CVCs (56% of which were PICCs); of 1,433 ward CVC-days, 361 (25.2%) were idle. At least 1 idle day was observed for 63% of patients. Patients had a mean of 4.1 idle days and a mean of 3.4 days with both a CVC and a peripheral intravenous catheter (PIV). After adjusting for ward length of stay, mean CVC dwell time was 14.4 days for patients with PICCs versus 9.0 days for patients with non-PICC temporary CVCs (other CVCs; ). Patients with a PICC had 5.4 days in which they also had a PIV, compared with 10 days in other CVC patients ( ). Patients with PICCs had more days in which the only justification for the CVC was intravenous administration of antimicrobial agents (8.5 vs 1.6 days; ). Conclusions. Significant proportions of ward CVC-days were unjustified. Reducing “idle CVC-days” and facilitating the appropriate use of PIVs may reduce CVC-days and CR-BSI risk.